What is USANA Health Sciences's hiya — SG&A?

USANA Health Sciences (USNA) reported hiya — SG&A of $24.77M in Q1 2026.

How has USANA Health Sciences's hiya — SG&A changed year-over-year?

USANA Health Sciences's hiya — SG&A increased by 5.4% year-over-year, from $23.51M to $24.77M.

What does hiya — SG&A mean?

Captures the operating expenses incurred by the Hiya segment that are not directly tied to the production of goods, such as marketing, administrative salaries, and overhead. This metric provides insight into the operational leverage and cost management discipline of the segment. It helps investors understand the overhead burden required to support the segment's business activities.

USANA Health Sciences USNA Hiya — SG&A

Other segment segments

Core Nutritional

$60.75M—

Rise

$2.74M—

Similar metrics at other companies

BXCSG&A - sales — Selling, general and administrative expense

$18.19M+2.4%

SYYOther — Selling, general & administrative expense

$32M+6.7%

RBAReportable Segment — SG&A

$214.2M+4.5%

NXHardware Solutions — SG&A

$35.76M+10.9%

HDPrimary Segment — SG&A

$7.36B+2.7%

FICOSG&A

$144.1M+19.7%

Other financials

Income statement

See full

Revenue$250.2M+0.3%

Gross profit$190.8M-3.2%

Operating income$13.9M-11.5%

Net income$7.5M-20.1%

EPS (diluted)$0.41-16.3%

Balance sheet

See full

Cash & equivalents$165.7M-9.2%

Total debt$18.0M+10.8%

Total equity$543.6M+2.6%

Total assets$739.0M-1.0%

Cash flow

See full

Operating cash flow$9.8M-37.0%

CapEx$2.6M-5.6%

Free cash flow$7.1M-43.9%

Valuation

See full

Market cap$363.35M-36.1%

P/E18.1×+7.8×

P/S0.4×-0.3×

Profitability

See full

Gross margin77.6%-3.0pp

Operating margin3.8%-2.7pp

Net margin1.9%-4.4pp

FCF margin5.7%-1.1pp

Returns & leverage

See full

Return on equity3.2%-7.6pp

Debt / equity0×0.0×

Current ratio2.5×+0.5×

Where this comes from

Reported directly by USANA Health Sciences in its filing.

Tagged under the XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense.

The official record: USANA Health Sciences’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about USANA Health Sciences's hiya — sg&a.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI

Claude

Questions, answered.

What is USANA Health Sciences's hiya — SG&A?: USANA Health Sciences (USNA) reported hiya — SG&A of $24.77M in Q1 2026.
How has USANA Health Sciences's hiya — SG&A changed year-over-year?: USANA Health Sciences's hiya — SG&A increased by 5.4% year-over-year, from $23.51M to $24.77M.
What does hiya — SG&A mean?: Captures the operating expenses incurred by the Hiya segment that are not directly tied to the production of goods, such as marketing, administrative salaries, and overhead. This metric provides insight into the operational leverage and cost management discipline of the segment. It helps investors understand the overhead burden required to support the segment's business activities.